Bifiliz (Vigel), lyophilizate 5 doses 10 pcs

Bifiliz Vigel is a drug that normalizes intestinal microflora. It has immunomodulatory, antibacterial and anti-diarrheal action.

Therapeutic effect of Bifiliz Vigel is due to the presence of bifidobacteria within it, the action of which is aimed at normalizing the intestinal microflora and lysozyme as a natural protective factor of the gastrointestinal tract.

Living bifidobacteria with high antagonistic activity against a wide range of opportunistic and enteropathogenic microorganisms displace the latter from the intestinal microbiocenosis, creating favorable conditions for the normalization of microflora and improve metabolic processes, preventing the formation of prolonged intestinal diseases.

Lysocim has bifidogenic, immunomodulatory, anti-inflammatory effects, stimulates metabolic and reparative processes and erythropoiesis, improves digestion, increases anti-infectious and anti-toxic resistance of the body, has antibacterial action and exhibits synergistic with many antibiotics.

The optimal combination of bifidobacteria and lysozyme in Bifiliz Vigil allows to strengthen the therapeutic effect of each component and limit the use of antibiotics for the treatment of intestinal infections and selective decontamination.

Indications

BIFILIZ (VIGEL) is intended for use in adults and children of all age groups, starting from the first days of life.
for the treatment and prevention of dysbiosis of various origins and intestinal dysfunctions: in newborns and infants with early artificial and mixed feeding; in patients with secondary immunodeficiency conditions, including after cytostatic therapy; for severe infectious-inflammatory and purulent-septic diseases, against the background and after the use of broad-spectrum antibiotics;
for the treatment of acute intestinal infections of bacterial etiology, including dysentery, salmonellosis, foodborne toxic infections, especially in cases of severe intoxication and intolerance to antibiotics;
for the treatment of acute and chronic nonspecific diseases of the digestive tract, accompanied by inhibition of the reparative processes of the intestinal mucosa;
to prevent infectious and destructive complications (including necrotizing ulcerative colitis) in neonatal intensive care units, in premature infants with aggravated premorbid background, with mixed pathology (infectious and inflammatory diseases, threat of sepsis, malnutrition, anemia, atopic dermatitis, etc.), against the background of intensive care.

Special instructions

In patients with severe allergic conditions, Bifiliz should be used under medical supervision.

Bifiliz should not be dissolved in hot water and stored in dissolved form.

Active ingredient

Bifidobacterium bifidum, Lysozyme

Composition

Active substances
lysozyme
bifidobacterium bifidum

Contraindications

No contraindications or side effects have been identified.

Use with caution in case of egg white intolerance and other allergic conditions.

Side Effects

No contraindications or side effects have been identified.

Use with caution in case of egg white intolerance and other allergic conditions.

Action

The therapeutic effect of the drug is due to the presence of bifidobacteria in its composition, the action of which is aimed at normalizing the intestinal microflora, and lysozyme as a natural protective factor for the gastrointestinal tract.

Live bifidobacteria with high antagonistic activity against a wide range of opportunistic and enteropathogenic microorganisms displace the latter from the intestinal microbiocenosis, creating favorable conditions for normalizing microflora and improving metabolic processes, preventing the formation of protracted forms of intestinal diseases. Lysozyme has a bifidogenic, immunomodulatory, anti-inflammatory effect, stimulates metabolic, reparative processes and erythropoiesis, improves digestion, increases the body’s anti-infective and antitoxic resistance, has an antibacterial effect and exhibits synergism with many antibiotics.

The optimal combination of bifidobacteria and lysozyme in bifiliz makes it possible to enhance the therapeutic effect of each component and limit the use of antibiotics for the treatment of intestinal infections and selective decontamination of pathogenic microflora.

Storage conditions

Stored in a dry place, protected from light at a temperature of 2 to 10°C.
The dissolved drug cannot be stored.

Shelf life

2 years.

Manufacturer

Firm Enzyme LLC, Russia